BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37895143)

  • 41. Ferroptosis-based molecular prognostic model for adrenocortical carcinoma based on least absolute shrinkage and selection operator regression.
    Lin C; Hu R; Sun F; Liang W
    J Clin Lab Anal; 2022 Jun; 36(6):e24465. PubMed ID: 35500219
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The MQRG score: a novel prognostic tool for adrenocortical carcinoma patients based on mitochondrial quality.
    Chen T; Wang Y; Chen X; Zheng W; Guo W; Liang Q; Wang J; Chen Z; Zhou Y; Xiao L
    Front Endocrinol (Lausanne); 2024; 15():1222281. PubMed ID: 38505747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of glucocorticoid receptor (GR) and clinical significance in adrenocortical carcinoma.
    Wu K; Liu Z; Liang J; Zhang F; Zhang F; Wang Y; Lia T; Liu S; Zhu Y; Li X
    Front Endocrinol (Lausanne); 2022; 13():903824. PubMed ID: 35992138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
    Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
    Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma.
    Zhou Y; Li X; Long G; Tao Y; Zhou L; Tang J
    Front Immunol; 2022; 13():994259. PubMed ID: 36341373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Construction of a robust prognostic model for adult adrenocortical carcinoma: Results from bioinformatics and real-world data.
    Tian X; Xu WH; Anwaier A; Wang HK; Wan FN; Cao DL; Luo WJ; Shi GH; Qu YY; Zhang HL; Ye DW
    J Cell Mol Med; 2021 Apr; 25(8):3898-3911. PubMed ID: 33626208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 49. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
    Gao S; Zhang L; Wang H
    Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma.
    Cai Z; He Y; Yu Z; Hu J; Xiao Z; Zu X; Li Z; Li H
    Front Immunol; 2022; 13():933241. PubMed ID: 36211378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma.
    Gao Z; Man X; Li Z; Bi J; Liu X; Li Z; Zhu Y; Zhang Z; Kong C
    Oncol Rep; 2019 Apr; 41(4):2440-2452. PubMed ID: 30816525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration.
    Long M; Zhou Z; Wei X; Lin Q; Qiu M; Zhou Y; Chen P; Jiang Y; Wen Q; Liu Y; Li R; Zhou X; Yu H
    Front Immunol; 2022; 13():1023349. PubMed ID: 36353638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of STEAP3-based molecular subtype and risk model in ovarian cancer.
    Zhao Z; Sun C; Hou J; Yu P; Wei Y; Bai R; Yang P
    J Ovarian Res; 2023 Jun; 16(1):126. PubMed ID: 37386521
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Construction of an immune infiltration landscape based on immune-related genes in cervical cancer.
    Yang Y; Wang N; Shi X; Wang Y; Yang C; Fan J; Jia X
    Comput Biol Med; 2022 Jul; 146():105638. PubMed ID: 35605489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.
    Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comprehensive Analysis of TRP Channel-Related Genes for Estimating the Immune Microenvironment, Prognosis, and Therapeutic Effect in Patients With Esophageal Squamous Cell Carcinoma.
    Zhao F; Gao S; Qin X; Niu R; Li Z; Wang C; Li S
    Front Cell Dev Biol; 2022; 10():820870. PubMed ID: 35309940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma.
    Xiao Y; Li J; Wu J
    BMC Med Genomics; 2023 Jul; 16(1):177. PubMed ID: 37525171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy.
    Hong K; Cen K; Chen Q; Dai Y; Mai Y; Guo Y
    Front Immunol; 2023; 14():1128390. PubMed ID: 36761753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of tumor-infiltrating immune cells and prognostic validation of tumor-infiltrating mast cells in adrenocortical carcinoma: results from bioinformatics and real-world data.
    Tian X; Xu W; Wang Y; Anwaier A; Wang H; Wan F; Zhu Y; Cao D; Shi G; Zhu Y; Qu Y; Zhang H; Ye D
    Oncoimmunology; 2020 Jun; 9(1):1784529. PubMed ID: 32923148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of TGF-β signaling-related molecular patterns, construction of a prognostic model, and prediction of immunotherapy response in gastric cancer.
    Zeng C; He R; Dai Y; Lu X; Deng L; Zhu Q; Liu Y; Liu Q; Lu W; Wang Y; Jin J
    Front Pharmacol; 2022; 13():1069204. PubMed ID: 36467074
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.